NEW YORK, Jan. 28, 2026  /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful conclusion of its Gynecological Microwave Ablation Masterclass in Shanghai. Led by Dr. Xiaoming Gong of Weheal, the program offered a rigorous curriculum designed to advance procedural expertise in the treatment of benign gynecological conditions using the Company's proprietary technology. The event featured a combination of expert-led didactic

NEW YORK, Jan. 26, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced a strategic partnership with Stonewood Key Capital, a wholly-owned comprehensive investment management enterprise from New Zealand. This collaboration positions the Hainan Free Trade Port as a pivotal hub for the Company's cross-border operations and supply chain, enabling more efficient capital allocation to accelerate the commercialization of its advanced medical solutions globally.

NEW YORK, Jan. 20, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful participation in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. During the conference week, the Company's leadership team, including U.S. CEO Mark Saxton, held a series of meetings with institutional investors and healthcare industry veterans. These discussions focused on Baird Medical's 2026 strategic priorities, specificall

NEW YORK, Jan. 7, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, today announced it has reached key regulatory milestones with official product registrations from both the Medical Device Board (MDB) of Pakistan and the Ministry of Health of Vietnam. In Pakistan, the Company successfully executed its official product launch at the Armed Forces Institute of Radiology & Imaging (AFIRI). The launch was conducted under the professional guidance of Dr. Raza Raheem,

NEW YORK, Dec. 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, today announced the establishment of a dedicated manufacturing base in the United States. This development marks a pivotal step in Baird Medical's transition from a specialized exporter to a comprehensive global medical technology enterprise. The decision to anchor production in North America is driven by the Company's rapid commercial success across over a dozen countries, including recent sign

NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, recently concluded an advanced MWA training session in New Orleans. This initiative reinforces the Company's commitment to accelerating the adoption of minimally invasive therapies through strategic physician education. The specialized training program was led by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine. The program provided advanced trai

NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the appointment of Mark Saxton as Chief Executive Officer of its U.S. subsidiary. Mr. Saxton is a seasoned medical device executive with more than 25 years of commercial leadership experience, including a decade advancing intravascular RF ablation technologies. He will lead all U.S. operations, including sales, marketing, and market development, as Baird Medical

NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its official launch into the Egyptian market with the successful completion of its first procedure at the prestigious Ain Shams Specialized Hospital. The landmark case involved a bone ablation performed by Dr. Amr Mahmoud. The patient, a 30-year-old male suffering from left thigh pain, was found to have a 1 x 1.5 cm bone lesion. The MWA procedure was completed safely and effectively, achieving fu

NEW YORK, Oct. 27, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the clinical adoption of its MWA system at Elk Medical, a prominent private endocrinology practice in Brooklyn, New York. Dr. Kazeem, a highly experienced endocrinologist with over 30 years of clinical practice, has performed nine MWA procedures in recent months. The procedures focused on treating patients with large thyroid nodules, offering a non-surgical alternative. The clinic reported that

NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of its first MWA procedure in Bangladesh. The landmark treatment was performed at USB Hospital in Uttara, Dhaka, marking a significant step forward in the availability of cutting-edge, non-surgical cancer therapies in the region. The procedure was led by Dr. Mofazzal Sharif Rasel, a distinguished interventional radiologist, and his expert medical team. The patient, a 65

424B3 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

EFFECT - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

F-1/A - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

6-K - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

F-1/A - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

20-F - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

NT 20-F - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

6-K - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

F-1/A - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

S-8 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the appointment of Mark Saxton as Chief Executive Officer of its U.S. subsidiary. Mr. Saxton is a seasoned medical device executive with more than 25 years of commercial leadership experience, including a decade advancing intravascular RF ablation technologies. He will lead all U.S. operations, including sales, marketing, and market development, as Baird Medical

NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation in the 3rd International Workshop on Thermal Ablation of Thyroid Tumor and Hyperparathyroidism. The prestigious academic event was hosted by the China-Japan Friendship Hospital in Beijing, China, from October 17-18, 2025. Chaired by Prof. Ming'an Yu, a leading authority in interventional medicine, the workshop served as a vital platform for the world's foremost experts to share